CoChat

microRNAs in Neurodegeneration: Current Findings and Potential Impacts

Open access
Sharma, Salil, Lu, Hui Chen · 2018 · Journal of Alzheimer’s Disease & Parkinsonism
Cited by 67

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Significant advancements have been made in unraveling and understanding the non-coding elements of the human genome. New insights into the structure and function of noncoding RNAs have emerged. Their relevance in the context of both physiological cellular homeostasis and human diseases is getting appreciated. As a result, exploration of noncoding RNAs, in particular microRNAs (miRs), as therapeutic agents or targets of therapeutic strategies is under way. This review summarizes and discusses in depth the current literature on the role of miRs in neurodegenerative diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4172/2161-0460.1000420

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Parkinson disease

    Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415

  • Non-coding RNAs in human disease

    Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825 · cited 1×

    “The non-protein coding genome comprises diverse sets of non-coding structures that include miRs, transcribed ultraconserved regions (T-UCRs), small nucleolar RNAs (snoRNAs), P-element induced wimpy testes (PIWI)-interacting RNAs (piRNAs), large intergenic noncoding RNAs (lincRNAs) and long non-coding RNAs (lncRNAs) [3…”
    Background
  • Visualization and analysis of gene expression in tissue sections by spatial transcriptomics

    Ståhl, P. L., Salmén, F., Vickovic, S., Lundmark, A., Navarro, J. F., Magnusson, J., Giacomello, S., Asp, M., Westholm, J. O., Huss, M., et al. (2016) · Science · doi:10.1126/science.aaf2403 · Cited by 3,834 · cited 1×

    “Many recent technological advances have resulted in studying the miR gain and loss of function studies [174,175], epigenetic regulation [176], miR regulated intricate network pathways using systems biology and bioinformatics approaches [177-179], and development of various transcriptomic screens [180,181].”
    Background
  • Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

    Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · cited 1×

    “For example, the polymorphic alleles of the enzyme APOE, involved in the transport of cholesterol, are strong risk factors in AD [97,98].”
    Background
  • Alzheimer’s Disease

    Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125

  • TREM2 Variants in Alzheimer's Disease

    Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 4×

    “They also reported that let7 is capable of activating intrinsic cell death pathway in cultured neurons via Toll-like receptor 7 (TLR7).”
    BackgroundInfluential
  • TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

    Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630 · cited 1×

    “These include mutations in TAR DNA binding protein (TDP-43), superoxide dismutase 1(SOD1), heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and fused in sarcoma (FUS) genes [119-123].”
    Background
  • Identification of Mammalian microRNA Host Genes and Transcription Units

    Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L., & Bradley, A. (2004) · Genome Research · doi:10.1101/gr.2722704 · Cited by 2,128 · cited 1×

    “The majority of miRs are located in defined TUs, and can be further classified as: (1) Intronic miRs in coding TU, (2) Intronic miRs in non-coding TU, (3) Exonic miRs in coding TU, and (4) Exonic miRs in non-coding TU [14].”
    Background
  • Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.

    Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060 · cited 4×

    “Volume 8 Issue 1 • 1000420 J Alzheimers Dis Parkinsonism, an open access journal ISSN:2161-0460 sequestering of miR-mRNA protein complexes into processing bodies called P-bodies [29,32,33].”
    BackgroundInfluential
  • The Cellular Phase of Alzheimer’s Disease

    De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · cited 1×

    “These changes subsequently progress to full clinical manifestation of AD [58].”
    Background

Show all 53 references

Cited by

See all 67

Metadata

Authors
Sharma, S., & Lu, H. C.
Venue
Journal of Alzheimer’s Disease & Parkinsonism
Published
2018
Volume
08
Issue
01
ISSN
2161-0460 (ISSN-L)
OpenAlex
W2791869864
Cited by
67
References
53
FWCI
2.64
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: microRNAs in Neurodegeneration: Current Findings and Potential Impacts. https://app.cochat.ai/papers/10.4172/2161-0460.1000420
The paper
Sharma, S., & Lu, H. C. (2018). microRNAs in Neurodegeneration: Current Findings and Potential Impacts. Journal of Alzheimer’s Disease & Parkinsonism. https://doi.org/10.4172/2161-0460.1000420

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.